Carlo Lucchesi

B cells are associated with survival and immunotherapy response in sarcoma

Florent Petitprez, Aurélien de Reyniès, Emily Z. Keung et al. · Nature · 2020 · 1.9K citations · Full text

Medicine, Immunology, Oncology +17

Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study

Antoîne Italiano, Jean‐Charles Soria, Maud Toulmonde et al. · The Lancet Oncology · 2018 · 614 citations

Medicine, Oncology, Pharmacology +12

Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren’s syndrome

Jacques‐Eric Gottenberg, Nicolas Cagnard, Carlo Lucchesi et al. · Proceedings of the National Academy of Sciences · 2006 · 591 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion

Gaëlle Pierron, Franck Tirode, Carlo Lucchesi et al. · Nature Genetics · 2012 · 468 citations

Medicine, Genetics, Oncology +10

Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity

Frédéric Chibon, Pauline Lagarde, Sébastien Salas et al. · Nature Medicine · 2010 · 464 citations

Medicine, Bioinformatics, Oncology +16